Ya Chen T Shih

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. pmc Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
    Chun Ru Chien
    Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan
    Clinicoecon Outcomes Res 4:201-8. 2012
  2. doi request reprint Economic burden of renal cell carcinoma in the US: Part II--an updated analysis
    Ya Chen T Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Pharmacoeconomics 29:331-41. 2011
  3. doi request reprint Economic burden of renal cell carcinoma: Part I--an updated review
    Ya Chen T Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Pharmacoeconomics 29:315-29. 2011
  4. doi request reprint Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study
    Grace L Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 116:734-41. 2010
  5. doi request reprint Adoption of intensity-modulated radiation therapy for breast cancer in the United States
    Benjamin D Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX 77030, USA
    J Natl Cancer Inst 103:798-809. 2011
  6. doi request reprint Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States
    Grace L Smith
    Department of Radiation Oncology, The Section of Health Services Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Am Coll Surg 209:425-433.e2. 2009
  7. doi request reprint Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care
    Grace L Smith
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 29:157-65. 2011
  8. ncbi request reprint Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients
    Elenir B C Avritscher
    Division of Quantitative Sciences, Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230, USA
    J Support Oncol 8:242-51. 2010
  9. ncbi request reprint Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
    Elenir B C Avritscher
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard Unit 196, Houston, TX 77030 4009, USA
    Support Care Cancer 12:531-6. 2004
  10. doi request reprint In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample
    Jeffrey A Jones
    Health Services Research Section, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 112:1096-105. 2008

Collaborators

Detail Information

Publications12

  1. pmc Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
    Chun Ru Chien
    Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan
    Clinicoecon Outcomes Res 4:201-8. 2012
    ..The objective of this review is to assess published economic evaluation of BEV in the treatment of non-small cell lung cancer (NSCLC)...
  2. doi request reprint Economic burden of renal cell carcinoma in the US: Part II--an updated analysis
    Ya Chen T Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Pharmacoeconomics 29:331-41. 2011
    ..Following an updated review of RCC-related economic studies, we supplemented the costs of RCC reported in the literature with estimates from the latest US databases that capture the utilization of several newly approved targeted agents...
  3. doi request reprint Economic burden of renal cell carcinoma: Part I--an updated review
    Ya Chen T Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Pharmacoeconomics 29:315-29. 2011
    ..More research is needed to assess the quality of the economic studies of RCC and to understand why the estimated costs differ across studies...
  4. doi request reprint Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study
    Grace L Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 116:734-41. 2010
    ..Therefore, in a comprehensive, national cohort of Medicare patients, racial disparities in the use of radiotherapy (RT) after breast-conserving surgery (BCS) for invasive breast cancer were quantified...
  5. doi request reprint Adoption of intensity-modulated radiation therapy for breast cancer in the United States
    Benjamin D Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX 77030, USA
    J Natl Cancer Inst 103:798-809. 2011
    ..It is thus controversial whether such treatment justifies billing for intensity-modulated radiation therapy (IMRT)...
  6. doi request reprint Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States
    Grace L Smith
    Department of Radiation Oncology, The Section of Health Services Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Am Coll Surg 209:425-433.e2. 2009
    ..But earlier studies report low BCS use rates of 12% to 43% nationally, especially in older patients. We sought to determine current patterns and predictors of BCS use...
  7. doi request reprint Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care
    Grace L Smith
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 29:157-65. 2011
    ..It is currently used in the community setting, although its efficacy has yet to be validated in prospective comparative trials. Frequency and factors influencing use have not been previously identified...
  8. ncbi request reprint Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients
    Elenir B C Avritscher
    Division of Quantitative Sciences, Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230, USA
    J Support Oncol 8:242-51. 2010
    ..The cost-utility of palonosetron-based therapy exceeds the $100,000/QALY threshold. Future research incorporating the price structure of all antiemetics following ondansetron's recent patent expiration is needed...
  9. ncbi request reprint Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
    Elenir B C Avritscher
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard Unit 196, Houston, TX 77030 4009, USA
    Support Care Cancer 12:531-6. 2004
    ....
  10. doi request reprint In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample
    Jeffrey A Jones
    Health Services Research Section, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 112:1096-105. 2008
    ..Complications remain common, but population-based estimates of their frequency and relative contribution to cost are not available...
  11. doi request reprint A review of economic impact of targeted oral anticancer medications
    Chan Shen
    Departments of Health Services Research and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Expert Rev Pharmacoecon Outcomes Res 14:45-69. 2014
    ..Our review raises a concern regarding the role of sponsorship on findings of economic analyses as the vast majority of pharmaceutical company-sponsored studies reported cost advantages toward the sponsor's drugs. ..
  12. doi request reprint Risk of hypothyroidism in older breast cancer patients treated with radiation
    Grace L Smith
    Department of Breast Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:1371-9. 2008
    ..The authors assessed risk of hypothyroidism in breast cancer patients who were receiving RT to a supraclavicular field, which typically includes a portion of thyroid...